REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06161441 updates: 1. primary completion date: 2026-04-17 → 2026-04-20 2. enrollment: not set → 195 participants
Clinical trial NCT06161441 updates: 1. primary completion date: 2026-04-17 → 2026-04-20 2. enrollment: not set → 195 participants
Clinical trial NCT06833073: enrollment: not set → 308 participants.
Clinical trial NCT05804318: enrollment: not set → 132 participants.
Clinical trial NCT07554365 updates: 1. start date: 2026-05-01 → 2026-05-13 2. enrollment: not set → 24 participants
Clinical trial NCT07091630: enrollment: not set → 160 participants.
Clinical trial NCT06619847: enrollment: not set → 367 participants.
Clinical trial NCT04248829 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-04-22 3. enrollment: not set → 393 participants
Clinical trial NCT05638802: enrollment: not set → 26 participants.
Clinical trial NCT05094336 updates: 1. completion date: 2028-05-29 → 2026-11-30 2. primary completion date: 2026-05-27 → 2026-11-30 3. enrollment: not set → 329 participants
Clinical trial NCT05289986: enrollment: not set → 19 participants.